BioSpace News Archive

Business

West and SCHOTT Announce Partnership to combine the SCHOTT iQ® Platform with West’s Ready Pack™ System

Supports Global Customers Seeking High-quality, Ready-to-use Packaging Products

November 6, 2019
·
7 min read
Genetown

EpiVax Announces Publication of Antigen-Specific Tolerance Induction by Tregitope in Nature Scientific Reports

EpiVax, Inc., a pioneer in immunoinformatics innovation, announces the publication of “Therapeutic administration of Tregitope-Human Albumin Fusion with Insulin Peptides to promote Antigen-Specific Adaptive Tolerance Induction” in Scientific Reports, 06 Nov 2019, a Nature publication.

November 6, 2019
·
2 min read
Business

Mersana Therapeutics Announces Third Quarter 2019 Financial Results and Provides Business Updates

Mersana Therapeutics, Inc. reported financial results and a business update for the third quarter ended September 30, 2019.

November 6, 2019
·
9 min read
Drug Development

Alzheon Publication Defines New Path for 2nd Generation Anti-Amyloid Drugs for Alzheimer’s Disease, Supporting Launch of Phase 3 Study with ALZ-801 Oral Tablet

Publication in Alzheimer’s & Dementia, The Journal of the Alzheimer’s Association, Details Scientific Underpinnings for ALZ-801 to Slow or Stop Disease Course

November 6, 2019
·
7 min read
Business

Voyager Therapeutics Announces Third Quarter 2019 Financial Results and Corporate Highlights

Voyager Therapeutics, Inc., a clinical-stage gene therapy company focused on developing life-changing treatments for severe neurological diseases, reported its third quarter 2019 financial results, program progress and corporate updates.

November 6, 2019
·
9 min read
Business

Achieve Reports Financial Results for Third Quarter 2019 and Provides Update on Cytisinicline Development Program

Achieve Life Sciences, Inc. provided an update on the cytisinicline clinical development program and announced third quarter 2019 financial results.

November 6, 2019
·
7 min read
Business

Amneal Enters into a Licensing Agreement with Kashiv BioSciences, LLC to Develop and Commercialize K127 for the Treatment of Myasthenia Gravis

Expands Amneal’s Central Nervous System (CNS) Focused Development Pipeline with Orphan Drug

November 6, 2019
·
5 min read
Business

CVS Health Reports Third Quarter Results

2019 EPS Guidance Raised And Narrowed, Reflecting Strong Execution Of Strategic Long-Term Plan

November 6, 2019
·
51 min read
Business

Madrigal Pharmaceuticals Reports 2019 Third Quarter Financial Results and Highlights

Madrigal Pharmaceuticals, Inc. announced its third quarter 2019 financial results and highlights

November 6, 2019
·
10 min read
Business

ProQR Announces Recent Progress and Financial Results for the Third Quarter of 2019

Encouraging clinical data reported from Phase 1/2 trial of sepofarsen for LCA10

November 6, 2019
·
12 min read